Skip to main content

Articles

Page 1 of 4

  1. Medication adherence plays an essential role in controlling blood pressure to reduce morbidity and mortality of hypertension disease. Thus, this study aimed to determine the association of medication adherence...

    Authors: Iin Ernawati, Eziah Ika Lubada, Ria Lusiyani and Rahmad Aji Prasetya
    Citation: Clinical Hypertension 2022 28:12
  2. Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely rep...

    Authors: Jina Yeo, Nami Shin, Kyung-Jin Ahn, Miryoung Seo, Albert Youngwoo Jang, Minsu Kim and Wook-Jin Chung
    Citation: Clinical Hypertension 2022 28:10
  3. Hypertension impacts 1.1 billion people globally; many patients seek complementary and alternative medicine (CAM), as a result of adverse side effects from antihypertensive medications or because they believe ...

    Authors: Jeremy Y. Ng, Jane Jomy and Alexandra Vacca
    Citation: Clinical Hypertension 2022 28:9
  4. Hypertension is common in continuous ambulatory peritoneal dialysis (CAPD) patients. It remains to be determined the extent to which fluid overload contributes to uncontrolled blood pressure (BP) in this popul...

    Authors: Adriaan Slabbert and Mogamat-Yazied Chothia
    Citation: Clinical Hypertension 2022 28:8
  5. This study evaluated the circadian efficacy of a telmisartan 40 mg/S-amlodipine 2.5 mg fixed-dose combination (Telmisartan40/S-Amlodipine2.5) compared to telmisartan 80 mg (Telmisartan80) in patients with esse...

    Authors: Bong-Joon Kim, Kyoung-Im Cho, Hyuck Moon Kwon, Seung-Min Choi, Chang-Hwan Yoon, Sang Wook Lim, Seung-Jae Joo, Nam Ho Lee, Sang-Yup Lim, Seong-Hoon Lim and Hyo-Soo Kim
    Citation: Clinical Hypertension 2022 28:7
  6. Hypertension is a well-recognized risk factor for the development of cardiovascular disease, and the early detection of cardiac changes from hypertension can allow reversing these. Hypertensive heart diseases ...

    Authors: Jin Kyung Oh and Jae-Hyeong Park
    Citation: Clinical Hypertension 2022 28:6
  7. Blood pressure variability (BPV) and arterial stiffness show an association with increased cardiovascular events. Evidences demonstrated an association between higher short-term systolic BPV and stiffer arteri...

    Authors: Marco Antonio Vieira Silva, Luiz Antonio Pertilli Rodrigues Resende, Mateus Marchiori Vieira, Camila Blanco Ferreira Jajah, Lucas Alves Berzotti, Nicole Cristine Rambourg, Ian Dias de Souza Pierson, João Lucas Carvalho Achkar, Livia Marchiori Vieira, Guilherme Marchiori Moreira, Geisa Ribeiro Borges and Dalmo Correia
    Citation: Clinical Hypertension 2022 28:5
  8. The signs and symptoms of pheochromocytoma can imitate those of many other diseases, which may result in confusion. Therefore, diagnosing and treating secondary hypertension due to pheochromocytoma in deterior...

    Authors: Sodam Jung and In Sook Kang
    Citation: Clinical Hypertension 2022 28:4
  9. We sought to determine the association between appendicular adiposity and hypertension, with the purpose of better understanding the role of body fat distribution on blood pressure (BP).

    Authors: Aayush Visaria, David Lo, Pranay Maniar, Bhoomi Dave and Parag Joshi
    Citation: Clinical Hypertension 2022 28:3
  10. Cardiovascular disease is one of the leading causes of death globally with hypertension being a primary cause of premature death from this disease process. Individuals with a family history of cardiovascular d...

    Authors: Linda P. Bolin, Amelia D. Saul, Lauren L. Bethune Scroggs and Carolyn Horne
    Citation: Clinical Hypertension 2022 28:2
  11. The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2021 to provide an overview of the magnitude and management status of hypertension and their recent trends.

    Authors: Hyeon Chang Kim, Hokyou Lee, Hyeok-Hee Lee, Eunsun Seo, Eunji Kim, Jiyen Han and Ja-Young Kwon
    Citation: Clinical Hypertension 2022 28:1
  12. Chronic diseases like hypertension need comprehensive lifetime management. This study assessed clinical and patient-reported outcomes and compared them by treatment patterns and adherence at 6 months among unc...

    Authors: Il Suk Sohn, Chong Jin Kim, Byung-Su Yoo, Byung Jin Kim, Jae Woong Choi, Doo-Il Kim, Sang-Hak Lee, Woo-Hyuk Song, Dong Woon Jeon, Tae Jun Cha, Dae-Kyeong Kim, Seong-Hoon Lim, Chang-Wook Nam, Joon-Han Shin, Ung Kim, Jae-Jin Kwak…
    Citation: Clinical Hypertension 2021 27:26
  13. Preeclampsia is a pregnancy-specific condition which gets detected through hypertension and excessive protein excretion in urine. While preeclampsia used to be regarded as a self-limiting maternal condition wh...

    Authors: José Javier Reyes-Lagos and Eric Alonso Abarca-Castro
    Citation: Clinical Hypertension 2021 27:24
  14. It is not well-known which components of central blood pressure (CBP) are more influential to target organ damage (TOD). This study aimed to determine the relationship between CBP measurements and various type...

    Authors: Ki-Hyun Jeon, Hack-Lyoung Kim, Woo-Hyun Lim, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo and Myung-A Kim
    Citation: Clinical Hypertension 2021 27:23
  15. Night-time BP, especially non-dipper, is a stronger predictor of adverse cardiovascular outcomes. Ambulatory blood pressure monitoring (ABPM) is a gold standard for the detection of non-dippers but it often is...

    Authors: Chavalit Chotruangnapa, Titima Tansakun and Weranuj Roubsanthisuk
    Citation: Clinical Hypertension 2021 27:22
  16. In this prospective, multicenter, non-comparative observational study, the effectiveness and safety of the triple single-pill combination (SPC) of olmesartan/amlodipine/hydrochlorothiazide (OM/AML/HCTZ) were e...

    Authors: Il Suk Sohn, Sang-Hyun Ihm, Gee Hee Kim, Sang Min Park, Bum-Kee Hong, Chang Hoon Lee, Sang Hyun Lee, Dae-Il Chang, Sung-Pil Joo, Sang-Chan Lee, Yong-ho Lee, Dong Woon Jeon, Kyung Tae Jung, Si Jae Rhee, Yoon-Jin Cho and Chong-Jin Kim
    Citation: Clinical Hypertension 2021 27:21
  17. Preeclampsia/eclampsia (PE/E) contributes significantly to maternal, perinatal morbidity and mortality in Nigeria. The objectives of the study were to ascertain the prevalence, materno-fetal outcomes and socio...

    Authors: Godwin O. Akaba, Ubong I. Anyang and Bissallah A. Ekele
    Citation: Clinical Hypertension 2021 27:20
  18. Diseases of the heart and vascular system are the leading cause of mortality in the Philippines. Hypertension, the most important modifiable risk factor, has a prevalence rate of 28% and a control rate of 20%....

    Authors: Margarita M. Gutierrez and Rungpetch Sakulbumrungsil
    Citation: Clinical Hypertension 2021 27:19
  19. Estrogen therapy in early menopausal women decreases the risk of coronary heart disease and parenteral, but not oral, estrogen is reported to reduce blood pressure (BP). Progestogens are typically added to est...

    Authors: Byung-Koo Yoon, Jidong Sung, Yun-Mi Song, Soo-Min Kim, Kyung-A Son, Jun Hyun Yoo, Sung-Ji Park and Duk-Kyung Kim
    Citation: Clinical Hypertension 2021 27:18
  20. The prevalence of hypertension is increasing in Bangladesh, however, few recent studies investigated the proportion of people and factors associated with prevalence, awareness, and control of this condition in...

    Authors: Gulam Muhammed Al Kibria, Rajat Das Gupta and Jannatun Nayeem
    Citation: Clinical Hypertension 2021 27:17
  21. The aim of this study was to examine left ventricular (LV) function in untreated, newly diagnosed hypertensive patients with morning blood pressure surge (MBPS) status using three-dimensional (3D) speckle trac...

    Authors: Ami Kwon, Sang Hyun Ihm and Chan Seok Park
    Citation: Clinical Hypertension 2021 27:16
  22. It is most important to measure blood pressure (BP) exactly in treating hypertension. Recent recommendations for diagnosing hypertension clearly acknowledge that an increase in BP attributable to the “whitecoa...

    Authors: Cheol Ho Lee, Ji Hun Ahn, Joon Ha Ryu and Woong Gil Choi
    Citation: Clinical Hypertension 2021 27:15
  23. Coronary artery ectasia (CAE) is characterized by the enlargement of a coronary artery to 1.5 times or more than other non-ectasia parts of the vessel. It is important to investigate the association of differe...

    Authors: Mostafa Bahremand, Ehsan Zereshki, Behzad Karami Matin, Mansour Rezaei and Hamidreza Omrani
    Citation: Clinical Hypertension 2021 27:14
  24. Hypertension (HTN) is a risk factor for cardiovascular disease; therefore, it is imperative to risk stratify potential kidney donors during evaluation. Clinic blood pressure (CBP) measurement is inaccurate in ...

    Authors: Nabeel Aslam, Sobia H. Memon, Hani Wadei, Elizabeth R. Lesser and Shehzad K. Niazi
    Citation: Clinical Hypertension 2021 27:13
  25. Isolated systolic hypertension typically occurs in young males; however, its clinical significance is unknown. Given the prevalence of the hypertension and its contribution to global morbidity and mortality, a...

    Authors: Holly Scott, Matthew J. Barton and Amy N. B. Johnston
    Citation: Clinical Hypertension 2021 27:12
  26. There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) du...

    Authors: Si-Hyuck Kang, Dong-Hoon Lee, Kyung-Do Han, Jin-Hyung Jung, Sang-Hyun Park, Andrew M. Dai, Henry G. Wei, Chang-Hwan Yoon, Tae-Jin Youn, In-Ho Chae and Cheol-Ho Kim
    Citation: Clinical Hypertension 2021 27:11
  27. Arterial stiffness is associated with myocardial ischemia and incident coronary artery disease (CAD), and indexes of arterial stiffness are usually increased in patients with CAD. However, these indexes are of...

    Authors: Seong Taeg Kim, Yeekyoung Ko, Jong-Wook Beom, Ki Yung Boo, Jae-Geun Lee, Joon-Hyouk Choi, Song-Yi Kim and Seung-Jae Joo
    Citation: Clinical Hypertension 2021 27:5
  28. BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Kor...

    Authors: Kyoung Im Cho, Dong Woon Jeon, Hyo Seung Ahn, Dong Kyu Jin, Hyun Sang Lee, Jong-Young Lee, Hong-Seok Lim, Athanasios J. Manolis, Seung-Woon Rha and Sang Won Park
    Citation: Clinical Hypertension 2021 27:9
  29. The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.

    Authors: Hyeon Chang Kim, So Mi Jemma Cho, Hokyou Lee, Hyeok-Hee Lee, Jongmin Baek and Ji Eun Heo
    Citation: Clinical Hypertension 2021 27:8

    The Correction to this article has been published in Clinical Hypertension 2021 27:10

  30. It is known in some studies that higher the LDL-C, the greater the risk of developing cardiovascular disease. However, studies of the causal effects between LDL-C and hypertension are limited by their observat...

    Authors: Tae-Hwa Go, Kyeong Im Kwak, Ji-Yun Jang, Minheui Yu, Hye Sim Kim, Jang Young Kim, Sang Baek Koh and Dae Ryong Kang
    Citation: Clinical Hypertension 2021 27:7
  31. Previous studies that investigated association of height with prevalence and control of hypertension found mixed results. This cross-sectional study explored these associations among US adults (≥20 years).

    Authors: Rajat Das Gupta, Maxwell Akonde, Ibrahim Hossain Sajal and Gulam Muhammed Al Kibria
    Citation: Clinical Hypertension 2021 27:6
  32. Smartphone technology has spread rapidly around the globe. According to a report released by the Korea Information Society Development Institute, about 95% of Koreans aged more than 30 years old owned smartpho...

    Authors: Hae Young Lee, Dong-Ju Lee, Jongmo Seo, Sang-Hyun Ihm, Kwang-il Kim, Eun Joo Cho, Hyeon Chang Kim, Jinho Shin, Sungha Park, Il-Suk Sohn, Wook-Jin Chung, Sung Kee Ryu, Ki Chul Sung, Juhan Kim, Dae-Hee Kim and Wook Bum Pyun
    Citation: Clinical Hypertension 2021 27:4
  33. Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 pa...

    Authors: Ramin Hosseinzadeh, Mohammad Ali Sheikh Beig Goharrizi, Mansour Bahardoust, Akbar Ghorbani Alvanegh, Mohammad Reza Ataee, Mehdi Bagheri, Ensiyeh Shabani Navidiyan, Seyed Reza Hosseini Zijoud and Mohammad Heiat
    Citation: Clinical Hypertension 2021 27:3
  34. High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietar...

    Authors: Sepiso K. Masenga, Annet Kirabo, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, John R. Koethe, Leta Pilic and Sody M. Munsaka
    Citation: Clinical Hypertension 2021 27:2
  35. Hypertension is a major public health problem and a prominent risk factor for cardiovascular diseases. However, whether passive smoking exposure (PSE) is associated with the risk of hypertension is scarcely un...

    Authors: Onoja Matthew Akpa, Akinkunmi Paul Okekunle, Jeffery Osahon Asowata and Babatunde Adedokun
    Citation: Clinical Hypertension 2021 27:1
  36. Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstac...

    Authors: Jung-Yeon Choi, Kwang-il Kim and Cheol-Ho Kim
    Citation: Clinical Hypertension 2020 26:24
  37. Globally hypertension in adults is among the leading preventable cause of premature death, where a graded association from the childhood hypertension is well recognised. With the concurrent rise in obesity and...

    Authors: Mohd Ashraf, Mohd Irshad and Nazir Ahmed Parry
    Citation: Clinical Hypertension 2020 26:22
  38. According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower...

    Authors: Miguel Camafort, Josep Redón, Wook Bum Pyun and Antonio Coca
    Citation: Clinical Hypertension 2020 26:21
  39. The risk associated with serum uric acid (SUA) levels when within the normal range is unknown. This study aims to examine whether SUA within the normal range is a predictor of hypertension.

    Authors: Ryuichi Kawamoto, Daisuke Ninomiya, Taichi Akase, Kikuchi Asuka and Teru Kumagi
    Citation: Clinical Hypertension 2020 26:20
  40. This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemica...

    Authors: Ahmed Tijani Bawah, Francis Agyemang Yeboah, Salifu Nanga, Huseini Alidu and Robert A. Ngala
    Citation: Clinical Hypertension 2020 26:19
  41. Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potent...

    Authors: Tong-Yoon Kim, Sang-Hyun Ihm, Ji Woong Roh, Sungmin Lim, Chan-Seok Park and Hee-Yeol Kim
    Citation: Clinical Hypertension 2020 26:17
  42. Preeclampsia is a complex syndrome that is considered a disorder specific to pregnancy. However, research indicates that diffuse maternal endothelial damage may persist after childbirth. On the other hand, wom...

    Authors: Kassahun Fikadu, Feleke G/Meskel, Firdawek Getahun, Nega Chufamo and Direslign Misiker
    Citation: Clinical Hypertension 2020 26:16

Official journal of

Annual Journal Metrics

  • Speed
    44 days to first decision for all manuscripts
    58 days to first decision for reviewed manuscripts only
    117 days from submission to acceptance
    45 days from acceptance to publication

    Usage 
    225,917 Downloads (2021)
    114 Altmetric Mentions